IPO

	Innovent Biologics, Inc. (1801)

Cover Important Expected Timetable Contents Chairman's Letter Summary Definitions Glossary of Technical Terms Forward-looking Statements Risk Factors Waivers from Compliance with the Listing Rules and exemptions from the Companies (Winding Up and Miscellaneous Provisions) Ordinance Information about this Prospectus and the Global Offering Directors and Parties Involved in the Global Offering Corporate Information Industry Overview Regulations History, Development and Corporate Structure Business Financial Information Connected Transactions Share Capital Substantial Shareholders Cornerstone Investors Directors and Senior Management Future Plans and Use of Proceeds Underwriting Structure of the Global Offering How to Apply for Hong Kong Offer Shares Appendix I – Accountants’ Report Appendix II – Unaudited Pro Forma Financial Information Appendix III – Summary of the Constitution of the Company and Cayman Companies Law Appendix IV – Statutory and General Information Appendix V – Documents Delivered to the Registrar of Companies in Hong Kong and Available for Inspection Back Cover